Why Parents, Teens, and Children Should Question the COVID-19 Vaccine

Why Parents, Teens, and Children Should Question the COVID-19 Vaccine

There is no immediate threat of severe COVID-19 in the majority of Canadian children and adolescents.
  • As of May 28, 2021, there have been 259,308 confirmed cases of SARS-CoV-2 infections in Canadians 19 years and under. Of these, 0.48% were hospitalized, 0.06% were admitted to ICU, and 0.004% died1. Seasonal influenza is associated with more severe illness than COVID-19.2
Pfizer BioNTech’s clinical data in children are limited and provide no information on rare but serious adverse effects or long-term safety as well as efficacy.
  • Pfizer BioNTech’s study included 2,260 children and adolescents, 12-15 years of age, 1,131 of whom received the vaccine. This is a very small number of adolescents and does not permit an evaluation of rare but serious side-effects, such as effects that may happen in only 1:5,000 adolescents. Furthermore, with most of the adolescents followed for only 1 or 2 months after their 2nd dose, there is no data to support long-term safety.
All of the COVID-19 vaccines in Canada are “Authorized under Interim Ordersâ€.

The Canadian government is committed to ensuring the safety and effectiveness of all vaccines used in Canada. As such, Health Canada will continue to monitor the safety and effectiveness of the Pfizer BioNTech COVID-19 vaccine through its post-market surveillance system, which includes monitoring reports from healthcare professionals, patients and other sources. In addition, Health Canada will review data from clinical trials and other studies conducted by Pfizer BioNTech as well as other surveillance systems to ensure that the vaccine continues to meet its safety and efficacy standards.

COVID-19 vaccines authorized for use in Canada result in production of virus spike protein.

It is believed that these cells are involved in the production of other proteins and cytokines that help to activate the immune system.

It was assumed that the spike proteins do not end up in circulation;
however, this is being challenged by recent studies.
Recent studies indicate the spike protein, itself, may potentially be harmful.

In order to investigate the potential risks of the spike protein produced in response to vaccination, further research is needed. This should include animal studies to assess the effects of the spike protein on various organs and tissues, as well as clinical trials in humans to assess any potential adverse reactions. Additionally, it is important to consider the long-term effects of vaccination on children and adolescents, as well as any potential interactions with other medications or treatments they may be receiving. Finally, it is essential that all safety protocols are followed during vaccine development and administration.

Health Canada authorized the COVID-19 vaccines without biodistribution and pharmacokinetic studies on the virus spike protein.

1. How the spike protein is produced and how it functions in the body.
2. The potential risks associated with exposure to the spike protein, including any long-term effects.
3. How the spike protein interacts with other proteins and molecules in the body, and how this could affect health outcomes.
4. What measures can be taken to reduce or eliminate exposure to the spike protein, such as vaccines or treatments.
5. How different populations may be affected differently by exposure to the spike protein, and what steps can be taken to ensure equitable access to treatments or vaccines for those most at risk.

  • The spike protein is produced by the SARS-CoV-2 virus, which infects human cells. The vaccine nanoparticles are taken up by antigen presenting cells (APCs), such as dendritic cells and macrophages, which then present the spike protein to other immune cells, such as T cells. These T cells then mount an immune response against the virus.
  • The spike protein is not gaining access to the circulatory system. It is only present on the surface of the virus and does not enter the body when a person is infected with COVID-19.
  • No, the spike protein does not cross the blood-brain barrier. The blood-brain barrier is a protective layer of cells that prevents certain substances from entering the brain. The spike protein is too large to pass through this barrier.
  • No, the spike protein does not interfere with semen production or ovulation. The spike protein is a component of the SARS-CoV-2 virus, which is responsible for causing COVID-19. It is not known to have any effect on reproductive processes.
  • fetus

    At this time, there is no evidence that the spike protein of the SARS-CoV-2 virus crosses the placenta and impacts a developing baby or fetus. However, research is ongoing to better understand how the virus may affect pregnant women and their babies.

  • No, the spike protein is not excreted in the milk of lactating mothers.

    The S1 subunit of the spike protein is composed of amino acids 1-621, and it is responsible for binding to ACE2 receptors. It has been shown to be highly immunogenic, with antibodies generated against it being able to neutralize SARS-CoV-2 in vitro (Ogata et al., 2021). The mRNA-1273 vaccine from Moderna has been shown to induce high levels of S1-specific antibodies in vaccinated individuals, which suggests that the vaccine is effective at inducing an immune response against this important part of the virus (Ogata et al., 2021).

    The toxicity studies conducted with the Pfizer BioNTech vaccine do not allow for a safety assessment of the spike protein.

    In order to better understand the safety of the spike protein, additional studies should be conducted using animal models that have ACE2 receptors with higher binding affinities for the spike protein. This could include species such as humans, rhesus monkeys, or other primates. These studies should evaluate potential toxicity of the spike protein in these species and assess any potential long-term effects. Additionally, further research into the mechanism of action of the spike protein should be conducted in order to gain a better understanding of how it interacts with ACE2 receptors and its potential effects on human health.

    We must ensure that any vaccine is safe and effective for our children and adolescents before it is administered.

    We must also consider the potential long-term effects of the vaccine on our children and adolescents. We must be sure that any vaccine does not cause any adverse health effects in the future, such as infertility or other chronic illnesses. Additionally, we must ensure that any vaccine does not interfere with normal development or growth.

    Finally, we must take into account the social implications of vaccinating our children and adolescents. Vaccination may lead to a false sense of security, which could lead to an increase in risky behaviors among young people. It is important to educate our youth about the importance of continuing to practice social distancing, wearing masks, and following other safety protocols even after they have been vaccinated.

    Canadians should ask their health care providers and public health officials about the safety and efficacy of the vaccine, as well as any potential risks associated with it. They should also inquire about the availability of alternative treatments or preventive measures that may be more effective in preventing SARS-CoV-2 infection. Canadians should also consider whether they are comfortable with the potential long-term effects of a vaccine that has not been adequately tested for safety and efficacy.

    The Canadian government should be called upon to immediately suspend the mass vaccination program of children and adolescents until further research is conducted to address the potential pathogenicity of the spike protein. This research should include studies on the safety and efficacy of the vaccine, as well as its long-term effects on health. The government should also ensure that all information related to this research is made available to the public in a timely manner. Furthermore, it should ensure that any decisions regarding the mass vaccination program are based on sound scientific evidence and not influenced by political or economic interests.